Keywords: USA, Data exclusivity, Innovation

How do data exclusivity periods affect pharmaceutical innovation?

Article | 12 January 2011

Pharmaceutical companies and generic drug manufacturers have long been at odds over regulations about "data exclusivity," the period of time ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in